Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Share-based Compensation (2018 - 2022)

Rapid Therapeutic Science Laboratories' Share-based Compensation history spans 5 years, with the latest figure at -$118420.0 for Q4 2022.

  • For Q4 2022, Share-based Compensation changed N/A year-over-year to -$118420.0; the TTM value through Jun 2023 reached -$59210.0, down 159.68%, while the annual FY2022 figure was $20000.0, 0.0% changed from the prior year.
  • Share-based Compensation for Q4 2022 was -$118420.0 at Rapid Therapeutic Science Laboratories, down from $59210.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $440834.0 in Q3 2020 and bottomed at -$118420.0 in Q4 2022.
  • The 5-year median for Share-based Compensation is $15375.0 (2018), against an average of $65588.6.
  • The largest annual shift saw Share-based Compensation surged 4000.78% in 2020 before it tumbled 95.46% in 2021.
  • A 5-year view of Share-based Compensation shows it stood at $10750.0 in 2018, then skyrocketed by 433.33% to $57333.0 in 2019, then surged by 668.9% to $440834.0 in 2020, then crashed by 95.46% to $20000.0 in 2021, then crashed by 692.1% to -$118420.0 in 2022.
  • Per Business Quant, the three most recent readings for RTSL's Share-based Compensation are -$118420.0 (Q4 2022), $59210.0 (Q3 2022), and $59210.0 (Q2 2022).